Related Experiment Videos
Percutaneous transluminal angioplasty of stenosed aortocoronary bypass grafts
Insights
Percutaneous transluminal angioplasty effectively treated stenosed aortocoronary bypass grafts, achieving a 93% primary success rate. However, 50% recurrence necessitates ongoing management for improved patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Stenosed aortocoronary bypass grafts can cause disabling angina pectoris years after surgery.
- Re-intervention for graft stenosis is often necessary but carries risks.
Purpose of the Study:
- To evaluate the efficacy and safety of percutaneous transluminal angioplasty for stenosed aortocoronary bypass grafts.
- To assess the long-term clinical improvement and recurrence rates after angioplasty.
Main Methods:
- Percutaneous transluminal angioplasty was performed on 44 stenosed aortocoronary bypass grafts in 31 patients.
- Patients presented with angina 4 months to 7 years post-coronary bypass surgery.
- Outcomes including success rate, complications, and clinical improvement were monitored.
Main Results:
- A high primary success rate of 93% was achieved.
- Procedure-related myocardial infarction occurred in 4.5% of patients; no emergency surgery or mortality was reported.
- Despite a 50% recurrence rate, 62% of patients showed clinical improvement at a mean follow-up of 26 months.
Conclusions:
- Percutaneous transluminal angioplasty is a safe and effective initial treatment for stenosed aortocoronary bypass grafts.
- Recurrence is common, highlighting the need for long-term surveillance and management strategies.
- The procedure offers significant clinical benefit for patients with disabling angina due to graft stenosis.
Abstract:
During the period between October 1980 and December 1982, percutaneous transluminal angioplasty of stenosed aortocoronary bypass grafts was attempted 44 times in 31 patients who had developed disabling angina pectoris four months to seven years after coronary bypass surgery. The primary success rate was 93%. Two (4.5%) patients developed myocardial infarction related to the procedure. No emergency aortocoronary bypass surgery was required and there was no mortality. Although the primary success rate was high, the incidence of recurrence after one or more angioplasties was 50%. Despite this recurrence rate the condition of 10 of the first 16 (62%) patients was clinically improved after a mean follow up of 26 months.